NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
202 hedge funds and large institutions have $4.45B invested in NEVRO CORP. in 2020 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 56 reducing their positions, and 23 closing their positions.
91% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 23
46% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 56
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
32% more capital invested
Capital invested by funds: $3.38B → $4.45B (+$1.08B)
11% more funds holding
Funds holding: 182 → 202 (+20)
28% less call options, than puts
Call options by funds: $28.7M | Put options by funds: $39.6M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$164M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$76.5M |
| 3 |
BlackRock
New York
|
+$57.8M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$33.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.1M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$82.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$47.6M |
| 3 |
D.E. Shaw & Co
New York
|
-$27.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$24.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$22.8M |
NVRO Hedge Fund Activity: Q2 2020 in Review
202 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2020, worth a combined $4.45B — up 32% from $3.38B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new NVRO positions and 23 closed out — a net gain of 21 holders — while 82 added to existing stakes and 56 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was HealthCor Management, cutting an estimated $82.8M.
- 202 institutional investors held NEVRO CORP. (NVRO) as of Q2 2020, up from 182 in Q1 2020.
- Funds reported $4.45B of NEVRO CORP. stock for Q2 2020, up 32% quarter-over-quarter.
- 44 funds opened new NEVRO CORP. positions in Q2 2020 and 23 closed out, a net change of +21 holders.
- The largest NEVRO CORP. buyer in Q2 2020 was Fidelity Investments, an estimated $164M added.
- The largest NEVRO CORP. seller in Q2 2020 was HealthCor Management, an estimated $82.8M sold.
Based on aggregated 13F filings for Q2 2020.